Trial intelligence / Profile preview

Royalactin in Wagner Grade II Diabetic Foot Ulcers

NCT07509268Phase 2Completed

Sponsor
Universidad Autónoma de Nuevo León
Start
Sep 2022
Primary completion
Sep 2025
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) (2 arms), sponsored by Universidad Autónoma de Nuevo León. Primary endpoint: Ulcer measurement in square centimeters at 4 weeks. Started Sep 2022; status: completed.

02

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT07509268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07509268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call